• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2010 Fiscal Year Final Research Report

Retinoic acid metabolizing enzyme CYP26A1 is a candidate oncogene, and a possible therapeutic target for cancers.

Research Project

  • PDF
Project/Area Number 20590402
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Experimental pathology
Research InstitutionKochi University

Principal Investigator

OSANAI Makoto  Kochi University, 教育研究部・医療学系, 准教授 (60381266)

Co-Investigator(Renkei-kenkyūsha) LEE Gang-Hong  高知大学, 教育研究部・医療学系, 教授 (10261405)
Project Period (FY) 2008 – 2010
Keywords腫瘍 / 発癌 / レチノイン酸 / ビタミンA / 癌遺伝子
Research Abstract

Vitamin A deficiency (VAD) is associated with increased susceptibility to carcinogenesis in animal models and elevated risk for a number of human cancers. We found that the CYP26A1, the gene encoding a cytochrome P450 enzyme specifically involved in metabolic inactivation of retinoic acid (RA), the most active vitamin A derivative, is highly expressed in a number of variety types of cancer, including primary breast carcinomas. We also found that the state of reduced RA bioavailability caused by enhanced expression of CYP26A1 is sufficient to markedly increase tumorigenic and metastatic potential. Our observations provide strong evidence for oncogenic and cell survival properties of CYP26A1 in carcinogenesis, and suggest mechanisms whereby VAD might promote cancer development. We believe that specific drug-mediated inactivation of CYP26A1 may have a notable impact on malignant potential of human tumors, and these results show its potential feasibility of CYP26A1-inhibitory cancer therapies.

  • Research Products

    (14 results)

All 2010 2009 2008

All Journal Article (10 results) (of which Peer Reviewed: 10 results) Presentation (2 results) Book (2 results)

  • [Journal Article] Oncogenic and cell survival properties of the retinoic acid metabolizing enzyme2010

    • Author(s)
      Osanai M, Sawada N, Lee GH.
    • Journal Title

      CYP26A1. Oncogene 29

      Pages: 1135-1144

    • Peer Reviewed
  • [Journal Article] Emerging novel treatment strategies for diabetic eye diseases.2010

    • Author(s)
      Osanai M, Lee GH, Sawada N.
    • Journal Title

      Current Diabetic Reviews 6

      Pages: 35-41

    • Peer Reviewed
  • [Journal Article] Insulin-independent promotion of chemically induced hapatocellular tumor development in genetically diebetic mice.2010

    • Author(s)
      Yamasaki K, Hayashi Y, Okamoto S, Osanai M, Lee GH.
    • Journal Title

      Cancer Sci 101

      Pages: 65-72

    • Peer Reviewed
  • [Journal Article] Transmembrane proteins of tight junctions.2008

    • Author(s)
      Chiba H, Osanai M, Murata M, Kojima T, Sawada N.
    • Journal Title

      Biochim Biophys Acta 1778

      Pages: 588-600

    • Peer Reviewed
  • [Journal Article] Experimental effect of retinoic acids on apoptosis during the development of diabetic retinopathy.2008

    • Author(s)
      Nishikiori N, Osanai M, Chiba H, Kojima T, Inatomi S, Ohguro H, Sawada N.
    • Journal Title

      Clinical Ophthalmol 2

      Pages: 233-235

    • Peer Reviewed
  • [Journal Article] Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca^<2+> absorption between enterocytes.2008

    • Author(s)
      Fujita H, Sugimoto K, InatomiS, Maeda T, Osanai M, Uchiyama Y, Yamamoto Y, Sawada N, Chiba H.
    • Journal Title

      Mol Biol Cell 19

      Pages: 1912-1921

    • Peer Reviewed
  • [Journal Article] Expression of fascin-1, an actin-binding protein, in migrating hepatoblasts during rat liver development.2008

    • Author(s)
      Hayashi Y, Toda K, Saibara T, Okamoto S, Osanai M, Enzan H, Lee GH.
    • Journal Title

      Cell Tissue Res 334

      Pages: 219-226

    • Peer Reviewed
  • [Journal Article] IGF-I regulates tight-junction protein claudin-1 during differentiation of osteoblast-like MC3T3-E1 cells via a MAP-kinase pathway.2008

    • Author(s)
      Hatakeyama N, Kojima T, Iba K, Murata M, Thi MM, Spray DC, Osanai M, Chiba H, Ishiai S, Yamashita T, Sawada N.
    • Journal Title

      Cell Tissue Res 334

      Pages: 243-254

    • Peer Reviewed
  • [Journal Article] Transforming growth factor-beta induces epithelial to mesenchymal transition by down-regulation of claudin-1 expression and the fence function in adult rat hepatocytes.2008

    • Author(s)
      Kojima T, Takano K, Yamaguchi H, Murata M, Son S, Imamura M, Yamaguchi H, Osanai M, Chiba H, Himi T, Sawada N.
    • Journal Title

      Liver Int 28

      Pages: 534-545

    • Peer Reviewed
  • [Journal Article] Protein kinase C enhances tight junction barrier function of human nasal epithelial cells in primary culture by transcriptional regulation.2008

    • Author(s)
      Koizumi J, Kojima T, Ogasawara N, Murata M, kamekura R, Kurose M, Go M, Harimaya A, Murata M, Osanai M, Chiba H, Himi T, Sawada N.
    • Journal Title

      Mol Pharmacol 74

      Pages: 432-442

    • Peer Reviewed
  • [Presentation] レチノイン酸代謝酵素CYP26A1の癌遺伝子としての役割2010

    • Author(s)
      小山内誠、李康弘
    • Organizer
      日本癌学会総会
    • Place of Presentation
      大阪
    • Year and Date
      2010-09-23
  • [Presentation] レチノイン酸代謝酵素CYP26A1は乳癌で高発現している2010

    • Author(s)
      小山内誠、李康弘
    • Organizer
      日本病理学会総会
    • Place of Presentation
      東京
    • Year and Date
      2010-04-28
  • [Book] The tight junction, intercellular seal as a cell-signaling player - Protocols for examination for its status.(Turksen K (Ed.))2010

    • Author(s)
      Osanai M. Springer.
    • Publisher
      Claudins : Methods and Protocols (Methods in Molecular Biology).
  • [Book] Tight junctions.(Schwab M (Ed.))2009

    • Author(s)
      Osanai M. Springer.
    • Publisher
      Encyclopedia of Cancer, Second edition.

URL: 

Published: 2012-01-26   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi